Yu W, Li P, Zhou L, Yang M, et al. A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma. Blood 2025 Jan 15:blood.2024026401. doi: 10.1182/blood.2024026401.
PMID: 39813680